CareDx, Inc. (CDNA) stock
CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 12/3026% above fair value
$74.44−0.12 (-0.16%)
Close on Nov 18, 2026Market cap $3.91BP/E 31.1Yield –
CareDx net income
Net income is the profit left for shareholders after every expense, interest and tax.
CareDx's net income for the twelve months ending Sep 30, 2026 was $128.63M, up 82.6% year over year. For fiscal 2025 it was -$21.35M, down 140.6% from the year before. The highest annual figure on record is $52.55M in fiscal 2024.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$21.35M | -140.6% |
| FY2024 | Dec 31, 2024 | $52.55M | – |
| FY2023 | Dec 31, 2023 | -$190.28M | – |
| FY2022 | Dec 31, 2022 | -$76.61M | – |
| FY2021 | Dec 31, 2021 | -$30.66M | – |
| FY2020 | Dec 31, 2020 | -$18.71M | – |
| FY2019 | Dec 31, 2019 | -$21.97M | – |
| FY2018 | Dec 31, 2018 | -$46.76M | – |
| FY2017 | Dec 31, 2017 | -$55.47M | – |
| FY2016 | Dec 31, 2016 | -$39.47M | – |
| FY2015 | Dec 31, 2015 | -$13.71M | -1855.1% |
| FY2014 | Dec 31, 2014 | $781.00K | – |
| FY2013 | Dec 31, 2013 | -$3.54M | – |
| FY2012 | Dec 31, 2012 | -$5.06M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $19.29M | +1051.8% |
| Q2 FY2026 | Jun 30, 2026 | $110.64M | – |
| Q1 FY2026 | Mar 31, 2026 | $2.81M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.11M | -104.7% |
| Q3 FY2025 | Sep 30, 2025 | $1.68M | – |
| Q2 FY2025 | Jun 30, 2025 | -$8.57M | – |
| Q1 FY2025 | Mar 31, 2025 | -$10.35M | – |
| Q4 FY2024 | Dec 31, 2024 | $87.70M | – |
| Q3 FY2024 | Sep 30, 2024 | -$10.64M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.62M | – |
| Q1 FY2024 | Mar 31, 2024 | -$19.89M | – |
| Q4 FY2023 | Dec 31, 2023 | -$118.10M | – |
| Q3 FY2023 | Sep 30, 2023 | -$23.49M | – |
| Q2 FY2023 | Jun 30, 2023 | -$24.95M | – |
| Q1 FY2023 | Mar 31, 2023 | -$23.75M | – |
| Q4 FY2022 | Dec 31, 2022 | -$18.33M | – |
| Q3 FY2022 | Sep 30, 2022 | -$16.94M | – |
| Q2 FY2022 | Jun 30, 2022 | -$21.70M | – |
| Q1 FY2022 | Mar 31, 2022 | -$19.65M | – |
| Q4 FY2021 | Dec 31, 2021 | -$16.15M | – |
| Q3 FY2021 | Sep 30, 2021 | -$11.90M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.93M | – |
| Q1 FY2021 | Mar 31, 2021 | -$687.00K | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.52M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.82M | – |
| Q2 FY2020 | Jun 30, 2020 | -$6.56M | – |
| Q1 FY2020 | Mar 31, 2020 | -$5.82M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.78M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.81M | – |
| Q2 FY2019 | Jun 30, 2019 | -$7.85M | – |
| Q1 FY2019 | Mar 31, 2019 | -$7.53M | – |
| Q4 FY2018 | Dec 31, 2018 | -$3.76M | – |
| Q3 FY2018 | Sep 30, 2018 | -$19.97M | – |
| Q2 FY2018 | Jun 30, 2018 | -$14.06M | – |
| Q1 FY2018 | Mar 31, 2018 | -$8.97M | – |
| Q4 FY2017 | Dec 31, 2017 | -$31.67M | – |
| Q3 FY2017 | Sep 30, 2017 | -$14.27M | – |
| Q2 FY2017 | Jun 30, 2017 | -$3.97M | – |
| Q1 FY2017 | Mar 31, 2017 | -$5.56M | – |
| Q4 FY2016 | Dec 31, 2016 | -$15.48M | – |
See a number that looks wrong?